Trius Therapeutics TSRX Stock Research Pagewww.triusrx.com
"Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for serious, life-threatening infections" Lead program: tedezolid for acute bacterial skin and skin structure infections (ABSSSI) - click here for more information. For more detailed coverage, contact Jason Napadano of Zacks @JNapadano TSRX - archive of related blog posts and articles3/2012 Citi Healthcare conference - click for my notes.
|
|